OneSource Specialty Pharma Ltd. NSE: ONESOURCE | BSE: 544292

OneSource Specialty Pharma Ltd. Live Share Price Today, Share Analysis and Chart

Name: OneSource Specialty Pharma Ltd.: Is Infosys Ltd. worth buying?
Item: OneSource Specialty Pharma Ltd.
Rating: 1.327916625
Author: Trendlyne DVM scores

Weak Stock

about

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end \Contract Development and Manufacturing Operations ('CDM...

1994.30 -8.20 (-0.41%)

64.82% Gain from 52W Low

185.7K

NSE+BSE Volume

NSE 15 Jul, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Low Financial Strength

35.0 / 100

Expensive Valuation

7.8 / 100

Technically Bearish

28.4 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

2,279

1Yr Price target upside is 14%

4 analysts

OneSource Specialty Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

OneSource Specialty Pharma Ltd. Live Share Price Today, Share Analysis and Chart

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end \Contract Development and Manufacturing Operations ('CDM...

64.82% Gain from 52W Low

SWOT Analysis

OneSource Specialty Pharma Live Price Chart